Albany, NY -- (SBWIRE) -- 08/16/2017 -- Majority share in the global pharmaceutical packaging market is held by the leading five companies, rendering its vendor landscape consolidated. These companies are IMA S.P.A, Robert Bosch GmbH, Körber AG, Marchesini Group S.p.A, Marchesini Group S.p.A., and Uhlmann Pac-Systeme GmbH & Co. KG and together they held nearly 55.5% of the global pharmaceutical packaging equipment market in 2016. Besides exploring the latest in technology, these companies are actively engaged in consolidated market share via mergers and acquisitions, finds Transparency Market Research in a new study.

Most of the prominent companies in the market are engaged in product innovation to gain competitive advantage. "With the advent of novel technologies, the market will gain momentum in the coming years," said a lead TMR analyst. The global pharmaceutical packaging equipment market is forecast to exhibit a CAGR of 6.7% between 2017 and 2025. At this pace, the market's valuation will reach US$10.69 bn by the end of 2025, from US$5.97 in 2016.

Browse The Press Release: http://www.transparencymarketresearch.com/pressrelease/pharmaceutical-packaging-equipment-market.htm

The market can be broadly classified into primary packaging equipment and secondary packaging equipment, based on package type. Of these, the primary packaging equipment segment emerged dominant in 2016 and is expected to remain at the lead exhibiting a CAGR of 6.6% between 2017 and 2025. Regionally, North America held the dominant share of 31.8% in the global pharmaceutical packaging equipment market in 2016. The region has demonstrated a persistently rising investment in novel drug delivery techniques. The trend has particularly caught pace in the US and Canada.

Market to Derive Growth from Expansion of Pharmaceutical Industry

Growth in the pharmaceutical industry is primarily aimed at finding effective cure for ailments. While this cure could be in any form, the industry's task does not end with acquiring approval for the same. Rather, it has to focus on myriad aspects co-related with making available novel therapeutics, high-quality packaging being the prime concern. For medications and therapeutic products to reach customers safely, investment in advanced packaging is considered imperative. Growth in the pharmaceutical industry will therefore usher lucrative opportunities for the global pharmaceutical packaging equipment market.

The rising demand for patient compliance, novel medicaments, and environmental ethics have bolstered investment in the research and development of pharmaceutical packaging systems. Besides this, stringent regulations mandating the pharmaceutical industry to follow certain standards while dealing with drugs, as they can have direct impact on human lives, have compelled it to focus on advanced pharmaceutical packaging. Spurred by these factors the demand for pharmaceutical packaging equipment has considerably increased over the last few years. Also the demand for high-performing equipment will rise as companies look towards integrated packaging technologies.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6373

Using Refurbished Equipment in place of Advanced Pharmaceutical Packaging Equipment could Stall Growth

On the downside, the use of revamped packaging equipment can create problems for the market. In response to the increasing cost pressure, pharmaceutical companies are reevaluating their operational and manufacturing processes. Their target being able to deal with soaring costs while providing affordable medications to customers. Thus several companies across emerging nations, especially in Latin America and Asia Pacific are adopting refurbished equipment to reduce their cost burden. This in the long run can have a negative impact on the overall market. Nevertheless, with the growing demand from Asia Pacific, the drug manufacturing capacities of these companies could improve thus mitigating the aforementioned concern.